All Stories

  1. Distinct effects of ketogenic and non-ketogenic weight-loss diets on hepatic steatosis and mitochondrial metabolism in MASLD

    Article • Journal of Hepatology, February 2026, Elsevier

    Sami Qadri

  2. Hepatic insulin resistance is the basis of bile acid dysmetabolism in metabolic dysfunction-associated steatotic liver disease

    Article • November 2025, Cold Spring Harbor Laboratory Press

    Sami Qadri

  3. Genome-wide interaction study with body mass index identifies <i>CYP7A1</i> and <i>GIPR</i> as genetic modulators of metabolic dysfunction-associated steatotic liver disease

    Article • Clinical and Molecular Hepatology, October 2025, The Korean Association for the Study of the Liver (KAMJE)

    Sami Qadri

  4. A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease

    Article • Journal of Hepatology, May 2025, Elsevier

    Sami Qadri

  5. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

    Article • Nature Reports Stem Cells, December 2024, Springer Science + Business Media

    Sami Qadri

  6. Surveillance of the liver in type 2 diabetes: important but unfeasible?

    Article • Diabetologia, February 2024, Springer Science + Business Media

    Sami Qadri

  7. Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19]

    Article • Journal of Hepatology, February 2024, Elsevier

    Sami Qadri

  8. IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

    Article • Cell Reports Medicine, January 2024, Elsevier

    Sami Qadri

  9. Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

    Article • JHEP Reports, January 2024, Elsevier

    Sami Qadri

  10. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

    Article • Journal of Hepatology, January 2024, Elsevier

    Professor Nunzio Vicario, Sami Qadri

  11. The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease

    Article • Pathology, November 2023, Elsevier

    Sami Qadri

  12. Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients

    Article • Clinical Gastroenterology and Hepatology, November 2023, Elsevier

    Sami Qadri

  13. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

    Article • Clinical Gastroenterology and Hepatology, June 2023, Elsevier

    Sami Qadri

  14. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

    Article • Liver International, April 2023, Wiley

    Sami Qadri, Claudio Tripodo

  15. The quest for the missing links in fatty liver genetics: Deep learning to the rescue!

    Article • Cell Reports Medicine, December 2022, Elsevier

    Sami Qadri

  16. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles

    Article • Atherosclerosis, December 2022, Elsevier

    Sami Qadri

  17. Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease

    Article • European Journal of Gastroenterology & Hepatology, September 2022, Wolters Kluwer Health

    Sami Qadri

  18. Heterogeneity of phosphatidylcholine metabolism in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, July 2022, Elsevier

    Sami Qadri

  19. Hepatic insulin resistance is the basis of bile acid dysmetabolism in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, July 2022, Elsevier

    Sami Qadri

  20. Marked underestimation of liver fat content as measured by magnetic resonance versus histology—a systematic review and meta-analysis

    Article • Journal of Hepatology, July 2022, Elsevier

    Sami Qadri

  21. Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes

    Article • Extremophiles, June 2022, Springer Science + Business Media

    Sami Qadri

  22. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?

    Article • Scandinavian Journal of Gastroenterology, June 2022, Taylor & Francis

    Sami Qadri

  23. In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples

    Article • Frontiers in Microbiology, April 2022, Frontiers

    Sami Qadri

  24. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

    Article • Journal of Hepatology, March 2022, Elsevier

    Sami Qadri, Dr Amalia Gastaldelli

  25. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, February 2022, Elsevier

    Sami Qadri

  26. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2021, Endocrine Society

    Sami Qadri

  27. Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 2021, Wolters Kluwer Health

    Sami Qadri

  28. Parallel Sessions

    Article • Journal of Hepatology, July 2021, Elsevier

    Sami Qadri

  29. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity

    Article • Nutrients, January 2021, MDPI AG

    Sami Qadri

  30. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2020, Endocrine Society

    Sami Qadri

  31. The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue

    Article • Liver International, May 2020, Wiley

    Sami Qadri, Dr Amalia Gastaldelli

  32. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2

    Article • BMC Medical Genetics, August 2017, Springer Science + Business Media

    Sami Qadri